Internship

Co-Op – Immunology

IMM, & Cardiovascular, CV, Translational Research, Fall 2025

Confirmed live in the last 24 hours

Bristol-Myers Squibb

Bristol-Myers Squibb

10,001+ employees

Develops and delivers biopharmaceutical medicines

Biotechnology
Healthcare

Compensation Overview

$29 - $35Hourly

Daly City, CA, USA

Full-time on-site employment required for 40 hrs/week throughout the 6-month program.

Category
Bioinformatics
Genomics
Biology Lab & Research
Biology & Biotech
Required Skills
Data Analysis
Requirements
  • Current graduate student with good standing in biological science graduate program (required); a demonstrated emphasis in translational biomarkers (preferred).
  • Completion of at least first year in an accredited graduate degree program.
  • Availability for full-time on-site employment (40 hrs/week) throughout 6-month program period is a must (ensure that leave approval is granted by graduate degree program and advisor before applying).
  • Experience in wet lab experimentation, analysis & interpretation of results is required.
  • Interpersonal and collaboration skills, including the willingness and ability to foster working relationships with a range of stakeholders.
Responsibilities
  • Actively contribute to translational project which is aligned with IMM & CV Translational Research objectives and the CV portfolio and participate in BMS Co-op program requirements.
  • Responsibilities may include laboratory work, literature/data review, and/or computational analyses.
  • Present Co-op project in lab meetings and at the conclusion of the program.

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, particularly in oncology, immunology, and cardiovascular health. The company conducts extensive research and development to create new drugs, which are then sold after receiving regulatory approval. BMS also produces generic drugs that are affordable alternatives to their innovative medicines, ensuring they meet the same quality and safety standards. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, as well as its commitment to sustainability and corporate responsibility. The company's goal is to improve patient outcomes by providing access to effective and affordable healthcare solutions.

Company Stage

IPO

Total Funding

$33.7B

Headquarters

New York City, New York

Founded

1887

Simplify Jobs

Simplify's Take

What believers are saying

  • BMS's involvement in Nobel Prize-winning immunology research underscores its leadership in groundbreaking scientific advancements.
  • The robust pipeline of molecular glues and other innovative therapies promises significant revenue growth and market expansion.
  • Recognition in the Dow Jones Sustainability Index North America highlights BMS's commitment to corporate responsibility and sustainability, enhancing its reputation and stakeholder trust.

What critics are saying

  • The termination of strategic collaborations, such as with Eisai, could impact BMS's ability to bring new therapies to market efficiently.
  • Ongoing layoffs and restructuring efforts may lead to decreased employee morale and potential disruptions in operations.

What makes Bristol-Myers Squibb unique

  • Bristol Myers Squibb's dual focus on innovative and generic medicines allows it to cater to a broad spectrum of healthcare needs, unlike competitors who may focus solely on one area.
  • Their commitment to sustainability and ESG goals sets them apart in the biopharmaceutical industry, appealing to socially conscious investors and stakeholders.
  • BMS's extensive R&D investment in oncology, immunology, and cardiovascular diseases positions it as a leader in developing cutting-edge treatments for serious diseases.

Help us improve and share your feedback! Did you find this helpful?